Results here show that enhancing apoptosis with birinapant-sensitized HGSC cells to carboplatin specifically in tumours with high levels of cIAP in their CA125-negative subpopulation, and eliminated tumour burden in vivo. The gene discussed is MUC16; the disease is neoplasm.